Mesa Labs appoints Shiraz Ladiwala to board, grants CEO special PSUs

MESA LABORATORIES INC /CO/

Shiraz Ladiwala appointed to Board, effective Oct 28, 2021; board expands from 7 to 8 members.
Ladiwala retired from Thermo Fisher Scientific as SVP, Business Transformation Projects.
CEO Gary Owens granted special performance stock units with target of 40,000 shares.
PSU vesting tied to cumulative GAAP revenue (30% weight) and adjusted operating income (70%) over 3 years through Mar 31, 2024.
No shares vest if performance below 80% of target; vesting occurs in three annual tranches starting Oct 27, 2024.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shiraz Ladiwala

Director

MLAB · MESA LABORATORIES INC /CO/

Effective: 2021-10-28
Filed: October 29, 2021, 7:59 PM ET

Effective October 28, 2021, Mesa Laboratories, Inc’s (“Mesa”) Board of Directors (“Board”) increased the size of Mesa’s Board from seven to eight members and upon the recommendation of the Nominating and Governance Committee, appointed Shiraz Ladiwala to fill the newly-created vacancy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shiraz Ladiwala was appointed as Director at MESA LABORATORIES INC /CO/.

Action: appointed
Role: Director

Exact text from the filing

Effective October 28, 2021, Mesa Laboratories, Inc’s (“Mesa”) Board of Directors (“Board”) increased the size of Mesa’s Board from seven to eight members and upon the recommendation of the Nominating and Governance Committee, appointed Shiraz Ladiwala to fill the newly-created vacancy.

View on SEC.gov

MESA LABORATORIES INC /CO/ filing history →

Source: SEC EDGAR

accession 0001437749-21-024583

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.